Anuh Pharma Approves Key Director Reappointments and Revises Management Remuneration

Anuh Pharma Approves Key Director Reappointments and Revises Management Remuneration​

Members of Anuh Pharma Limited approved several significant corporate decisions at its 66th Annual General Meeting, including the re-appointment of key non-executive directors and the revision of remuneration payable to the Joint Managing Directors for the financial year 2026-27. The meeting also saw the approval of a new set of Memorandum of Association (MOA) and Articles of Association (AOA), subject to shareholder ratification.

The decisions covered director continuity, the appointment of a Cost Auditor, and changes in compensation for senior management.

Director Reappointments and Profiles​

At the Annual General Meeting held on August 12, 2026, both Mr. Bipin Nemchand Shah and Mr. Arun Lalchand Todarwal were re-appointed as Non-Executive Non-Independent Directors of Anuh Pharma Limited. Both appointments adhere to Section 152(6) of the Companies Act, 2013, as they were liable to retire by rotation.

Mr. Bipin Nemchand Shah (DIN: 00083244)
A Chemical Engineer, Mr. Shah is noted for his vast experience spanning nearly 50 years in the pharmaceutical field. He serves as the Vice Chairman of Anuh Pharma Ltd., a leading bulk drug manufacturing company, and holds roles as Director or Partner across other SK Group companies that operate within the pharmaceutical industry. His areas of interest include marketing and management. Mr. Shah also holds positions including President of Thane Belapur Industries Association and Managing Committee Member of Indian Merchant Chambers, Mumbai. Disclosure noted that Mr. Bipin Shah is the father of both Joint Managing Directors, Ritesh Shah and Vivek Shah.

Mr. Arun Lalchand Todarwal (DIN: 00020916)
Mr. Todarwal is a fellow member of the Institute of Chartered Accountants of India and has practiced as a Chartered Accountant since 1981. His professional assignments include Statutory Audits, Internal Audits, Management and Systems Audits, Due Diligences, Taxation, and International Taxation. Mr. Todarwal is affiliated with several expert bodies, including the Institute of Internal Auditors and the National Centre for Quality Management, Bombay. He has extensive experience that has qualified him as a panel auditor for the Registrar of Co-operatives Societies and the Official Liquidator, Mumbai High court. The company noted no inter-se relationship among directors regarding this appointment.

Cost Auditor Reappointment​

The members also approved the re-appointment of Mr. Ankit Kishor Chande, a Qualified Cost Accountant (Membership No.: 34051), as the Cost Auditor for the financial year ending March 2027. Mr. Chande’s firm has over 12 years of experience in areas such as Costing, Audit & Assurance, Consulting Advisory and Finance. The firm has served various industries, including Pharmaceutical, Chemical, and Construction.

Management Remuneration Revisions​

The meeting included the consideration and approval of revisions to the remuneration payable for the financial year 2026-27 for two Joint Managing Directors:

• Mr. Ritesh B. Shah (DIN: 02496729)
• Mr. Vivek Shah (DIN: 02878724)

Governance and Operational Approvals​

In addition to the managerial appointments, the company approved the adoption of a new set of Memorandum of Association (MOA) and Articles of Association (AOA), both in accordance with the Companies Act, 2013, pending final shareholder approval.

ANUHPHR Stock Price Movement​

Shares of Anuh Pharma Limited slipped on Friday to settle at ₹76.21, shedding ₹0.88 or 1.14% from the previous close. The stock traded through the day with a volume of 46,254 shares and reached a low of ₹76.00 during trading.